‘Tis the season — for drug corporations to spend tax windfalls buying back billions in stock while refusing to lower drug prices.
Welcome to the Week in Review in Prescription Drug Pricing!
1. AstroTurf: Activate! 

2. CEO carolers: “All I want for Christmas are my company’s own shares”

3. Now streaming

4. In honor of Alec Smith

5. THAWED: That laughable Pfizer price hike freeze